NeisVac-C

Meningococcal conjugate vaccine against Neisseria meningitidis group C · Pfizer

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NeisVac-C, covering 2015-05-21 to 2015-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216

See pricing